English
Insider transactions
EDGARTaysha Gene Therapies, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-16.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 12 transactions, 1,368,795 shares
- Sum of shares × price per share: 6,658,093.26
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–38 of 38
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-10 Filed 2026-07-10 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200,000 | 6.24 | 1,248,000Derived: shares × price per share. Exact value 1248000.00. | 936,410 | Direct (D) | Yes | F1, F2
| Open filing 0001665124-26-000013 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Long Alison S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 21,335 | 0 | — | 127,178 | Direct (D) | No | F1
| Open filing 0001891712-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Long Alison S Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,671 | 0 | — | 42,671 | Direct (D) | No | F2
| Open filing 0001891712-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Sepp-Lorenzino Laura Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 21,335 | 0 | — | 127,178 | Direct (D) | No | F1
| Open filing 0001777421-26-000005 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Sepp-Lorenzino Laura Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,671 | 0 | — | 42,671 | Direct (D) | No | F2
| Open filing 0001777421-26-000005 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Donenberg Phillip B. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 21,335 | 0 | — | 241,289 | Direct (D) | No | F1
| Open filing 0001238120-26-000008 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Donenberg Phillip B. Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,671 | 0 | — | 42,671 | Direct (D) | No | F2
| Open filing 0001238120-26-000008 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Stalfort John A III Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 21,335 | 0 | — | 1,176,559 | Direct (D) | No | F1
| Open filing 0001709418-26-000002 Read from the filing’s XML Dispute this row |
| 2026-06-01 Filed 2026-06-02 | Stalfort John A III Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 42,671 | 0 | — | 42,671 | Direct (D) | No | F3
| Open filing 0001709418-26-000002 Read from the filing’s XML Dispute this row |
| 2026-04-10 Filed 2026-04-13 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 19,021 | 1.71 | 32,525.91Derived: shares × price per share. Exact value 32525.91. | 1,336,410 | Direct (D) | Yes | — | Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row |
| 2026-04-10 Filed 2026-04-13 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200,000 | 4.46 | 892,000Derived: shares × price per share. Exact value 892000.00. | 1,136,410 | Direct (D) | Yes | F1, F2
| Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row |
| 2026-04-10 Filed 2026-04-13 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 19,021 | 0 | — | 455,920 | Direct (D) | Yes | F3
| Open filing 0001665124-26-000011 Read from the filing’s XML Dispute this row |
| 2026-02-04 Filed 2026-02-06 | Alam Kamran Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,655 | 4.52 | 7,480.6Derived: shares × price per share. Exact value 7480.60. | 1,442,131 | Direct (D) | No | F1
| Open filing 0001793412-26-000012 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-27 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 26,918 | 4.61 | 124,091.98Derived: shares × price per share. Exact value 124091.98. | 1,317,389 | Direct (D) | No | F1, F3
| Open filing 0001665124-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-27 | Nolan Sean P. Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 41,312 | 4.61 | 190,448.32Derived: shares × price per share. Exact value 190448.32. | 2,908,257 | Direct (D) | No | F1, F3
| Open filing 0001569926-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-26 Filed 2026-01-27 | Alam Kamran Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 23,849 | 4.61 | 109,943.89Derived: shares × price per share. Exact value 109943.89. | 1,443,786 | Direct (D) | No | F1, F3
| Open filing 0001793412-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-23 Filed 2026-01-27 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 89,132 | 4.75 | 423,377Derived: shares × price per share. Exact value 423377.00. | 1,344,307 | Direct (D) | No | F1, F2
| Open filing 0001665124-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-23 Filed 2026-01-27 | Nolan Sean P. Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 136,789 | 4.75 | 649,747.75Derived: shares × price per share. Exact value 649747.75. | 2,949,569 | Direct (D) | No | F1, F2
| Open filing 0001569926-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-23 Filed 2026-01-27 | Alam Kamran Officer: CHIEF FINANCIAL OFFICER | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 78,968 | 4.75 | 375,098Derived: shares × price per share. Exact value 375098.00. | 1,467,635 | Direct (D) | No | F1, F2
| Open filing 0001793412-26-000008 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nolan Sean P. Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 1,008,000 | 0 | — | 3,086,358 | Direct (D) | No | F1
| Open filing 0001569926-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nolan Sean P. Director · Officer: Chief Executive Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 648,000 | 0 | — | 648,000 | Direct (D) | No | F3
| Open filing 0001569926-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 111,324 | 0.6989 | 77,804.3436Derived: shares × price per share. Exact value 77804.3436. | 1,117,763 | Direct (D) | Yes | — | Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 88,676 | 1.71 | 151,635.96Derived: shares × price per share. Exact value 151635.96. | 1,206,439 | Direct (D) | Yes | — | Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 200,000 | 4.71 | 942,000Derived: shares × price per share. Exact value 942000.00. | 1,006,439 | Direct (D) | Yes | F1, F2
| Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 427,000 | 0 | — | 1,433,439 | Direct (D) | Yes | F3
| Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 111,324 | 0 | — | 111,359 | Direct (D) | Yes | F4
| Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 88,676 | 0 | — | 474,941 | Direct (D) | Yes | F5
| Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Nagendran Sukumar Director · Officer: President and Head of RD | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 274,000 | 0 | — | 274,000 | Direct (D) | Yes | F6
| Open filing 0001665124-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Alam Kamran Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 359,000 | 0 | — | 1,546,603 | Direct (D) | No | F1
| Open filing 0001793412-26-000002 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-14 | Alam Kamran Officer: CHIEF FINANCIAL OFFICER | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 231,000 | 0 | — | 231,000 | Direct (D) | No | F2
| Open filing 0001793412-26-000002 Read from the filing’s XML Dispute this row |
| 2025-12-01 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 260,047 | 1.71 | 444,680.37Derived: shares × price per share. Exact value 444680.37. | 1,266,486 | Direct (D) | No | — | Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-01 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 260,047 | 4.51 | 1,172,811.97Derived: shares × price per share. Exact value 1172811.97. | 1,006,439 | Direct (D) | No | F2
| Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-12-01 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 260,047 | 0 | — | 563,617 | Direct (D) | No | F4
| Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 70,172 | 0.6989 | 49,043.2108Derived: shares × price per share. Exact value 49043.2108. | 1,076,611 | Direct (D) | No | — | Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 39,953 | 1.71 | 68,319.63Derived: shares × price per share. Exact value 68319.63. | 1,116,564 | Direct (D) | No | — | Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 110,125 | 4.75 | 523,093.75Derived: shares × price per share. Exact value 523093.75. | 1,006,439 | Direct (D) | No | F1
| Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 70,172 | 0 | — | 222,683 | Direct (D) | No | F3
| Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
| 2025-11-28 Filed 2025-12-01 | Nagendran Sukumar Director · Officer: President and Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 39,953 | 0 | — | 823,664 | Direct (D) | No | F4
| Open filing 0001665124-25-000003 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| RA Capital Management, L.P. Common Stock, $0.00001 par value per share | 9.9 | 32,886,242.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001231919-26-000928 Dispute this row |
| Peter Kolchinsky Common Stock, $0.00001 par value per share | 9.9 | 32,886,242.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001231919-26-000928 Dispute this row |
| Rajeev Shah Common Stock, $0.00001 par value per share | 9.9 | 32,886,242.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001231919-26-000928 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share | 9.9 | 32,886,242.00 | 06/30/2026 Filed 2026-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001231919-26-000928 Dispute this row |
| Morgan Stanley Common Stock | 5.1 | 16,244,339 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0000895421-26-000269 Dispute this row |
| Morgan Stanley Capital Services LLC Common Stock | 5.0 | 16,001,130 | 06/30/2026 Filed 2026-08-13 | SCHEDULE 13G/AAmendment 2 | Open filing 0000895421-26-000269 Dispute this row |
| Vestal Point Capital, LP Common Stock, par value $0.00001 per share | 6.3 | 18,000,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-26-002553 Dispute this row |
| Ryan Wilder Common Stock, par value $0.00001 per share | 6.3 | 18,000,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 1 | Open filing 0000902664-26-002553 Dispute this row |
| RTW Investments, LP Common Stock, par value $0.00001 per share | 7.0 | 20,689,084.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 5 | Open filing 0001493215-26-000122 Dispute this row |
| Roderick Wong Common Stock, par value $0.00001 per share | 7.0 | 20,689,084.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 5 | Open filing 0001493215-26-000122 Dispute this row |
| RTW Investments, LP Common Stock, par value $0.00001 per share | 8.3 | 23,407,133.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 4 | Open filing 0001493215-26-000050 Dispute this row |
| Roderick Wong Common Stock, par value $0.00001 per share | 8.3 | 23,407,133.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G/AAmendment 4 | Open filing 0001493215-26-000050 Dispute this row |
| Vestal Point Capital, LP Common Stock, par value $0.00001 per share | 5 | 13,750,000.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0000902664-26-001081 Dispute this row |
| Ryan Wilder Common Stock, par value $0.00001 per share | 5 | 13,750,000.00 | 12/31/2025 Filed 2026-02-17 | SCHEDULE 13G | Open filing 0000902664-26-001081 Dispute this row |
| FMR LLC COMMON STOCK | 4.9 | 13,528,365.87 | 12/31/2025 Filed 2026-02-05 | SCHEDULE 13G/AAmendment 10 | Open filing 0000315066-26-000536 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 4.9 | 13,528,365.87 | 12/31/2025 Filed 2026-02-05 | SCHEDULE 13G/AAmendment 10 | Open filing 0000315066-26-000536 Dispute this row |
| BlackRock, Inc. Common Stock | 6.5 | 17,852,291 | 12/31/2025 Filed 2026-01-21 | SCHEDULE 13G/AAmendment 2 | Open filing 0002012383-26-000794 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.00001 par value per share | 9.9 | 27,662,481.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-25-000491 Dispute this row |
| Peter Kolchinsky Common Stock, $0.00001 par value per share | 9.9 | 27,662,481.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-25-000491 Dispute this row |
| Rajeev Shah Common Stock, $0.00001 par value per share | 9.9 | 27,662,481.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-25-000491 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share | 9.9 | 27,662,481.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 4 | Open filing 0001231919-25-000491 Dispute this row |
| Octagon Capital Advisors LP Common Stock, $0.00001 par value | 3.3 | 9,067,500.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-25-016718 Dispute this row |
| Octagon Investments Master Fund Common Stock, $0.00001 par value | 3.3 | 9,067,500.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-25-016718 Dispute this row |
| Ting Jia Common Stock, $0.00001 par value | 3.3 | 9,067,500.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 1 | Open filing 0001214659-25-016718 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.00001 par value per share | 9.9 | 25,345,988.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-022033 Dispute this row |
| Peter Kolchinsky Common Stock, $0.00001 par value per share | 9.9 | 25,345,988.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-022033 Dispute this row |
| Rajeev Shah Common Stock, $0.00001 par value per share | 9.9 | 25,345,988.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-022033 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.00001 par value per share | 9.9 | 25,345,988.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-022033 Dispute this row |
| RTW Investments, LP Common Stock, par value $0.00001 per share | 9.9 | 25,183,287.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021712 Dispute this row |
| Roderick Wong Common Stock, par value $0.00001 per share | 9.9 | 25,183,287.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 3 | Open filing 0001415889-25-021712 Dispute this row |
| FMR LLC COMMON STOCK | 6.2 | 15,627,821.87 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 9 | Open filing 0000315066-25-002098 Dispute this row |
| Abigail P. Johnson COMMON STOCK | 6.2 | 15,627,821.87 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 9 | Open filing 0000315066-25-002098 Dispute this row |
| Morgan Stanley Common Stock | 6.7 | 16,858,644 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000895421-25-000463 Dispute this row |
| Morgan Stanley Capital Services LLC Common Stock | 5.6 | 14,095,143 | 06/30/2025 Filed 2025-08-06 | SCHEDULE 13G/AAmendment 1 | Open filing 0000895421-25-000463 Dispute this row |
| BlackRock, Inc. Common Stock | 5.2 | 13,153,326 | 06/30/2025 Filed 2025-07-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0002052113-25-002549 Dispute this row |
| THE GOLDMAN SACHS GROUP, INC. Common Stock, par value $0.00001 per share | 5.1 | 12,748,968.00 | 06/26/2025 Filed 2025-07-03 | SCHEDULE 13G | Open filing 0000769993-25-000401 Dispute this row |
| GOLDMAN SACHS CO. LLC Common Stock, par value $0.00001 per share | 5.1 | 12,748,968.00 | 06/26/2025 Filed 2025-07-03 | SCHEDULE 13G | Open filing 0000769993-25-000401 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,093,437 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 40,015 |
| 2023 | 199,811 |
| 2024 | 186,415 |
| 2025 | 235,520 |
| 2026 | 254,737 |
Filings made before the SEC required XML are listed, not extracted.